Regal Healthcare Capital Partners Closes Fund IV Above Target at $610 Million

Regal Healthcare Capital Partners, a New York-based private equity firm specializing in healthcare services, has successfully closed its fourth private equity fund, RHCP IV, at a total of $610 million. The fund exceeded its original target of $550 million, with approximately $575 million raised from external commitments. This closing, announced on July 7, 2026, marks a significant milestone for Regal, which has accumulated nearly $1.3 billion across its first four funds since its inception in 2018.

Regal's strategy focuses on partnering with leading entrepreneurs in the healthcare services sector, aiming to enhance the quality and accessibility of care. Fund IV has garnered strong support from existing investors while also attracting new commitments from a diverse array of blue-chip investors, including prominent endowments, foundations, asset managers, consultants, and public pension plans. This expansion of the investor base reflects Regal's growing reputation and the increasing interest in healthcare investments, particularly in the lower-middle market segment.

The healthcare sector has been experiencing notable transformations, driven by a combination of demographic trends, technological advancements, and evolving patient needs. As the demand for high-quality healthcare services continues to rise, private equity firms like Regal are strategically positioned to capitalize on these trends. By targeting equity investments of approximately $75 million in companies with revenues ranging from $20 million to $100 million and EBITDA of $2 million to $10 million, Regal aims to identify and support businesses that can deliver innovative solutions in healthcare.

The successful fundraising for RHCP IV underscores the confidence investors have in Regal's management team and its investment strategy. The firm’s ability to attract significant capital from a diverse investor base is indicative of the robust appetite for healthcare investments, particularly as the sector continues to evolve in response to market demands. The involvement of Lazard as the exclusive placement agent and Kirkland & Ellis as legal counsel further emphasizes the professionalism and credibility associated with this fundraise.

Looking ahead, the implications of this successful fundraise extend beyond Regal itself, signaling a broader trend in the private equity landscape where healthcare remains a focal point for investment. As the sector continues to adapt to challenges and opportunities, firms like Regal are well-positioned to leverage their expertise and investor support to drive growth and innovation in healthcare services. The increasing flow of capital into this space suggests a sustained interest in improving healthcare delivery, which could lead to enhanced patient outcomes and a more efficient healthcare system overall.